tiprankstipranks
Trending News
More News >
JBT Marel (JBTM)
NYSE:JBTM
Advertisement

JBT Marel (JBTM) AI Stock Analysis

Compare
253 Followers

Top Page

JBTM

JBT Marel

(NYSE:JBTM)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 4o)
Rating:70Outperform
Price Target:
$156.00
▲(13.58% Upside)
JBT Marel's strong revenue growth and effective cash flow management are key strengths, supported by positive technical indicators. However, profitability challenges and valuation concerns weigh on the score. Recent corporate actions and positive earnings call sentiment provide additional support.
Positive Factors
Revenue Growth
The robust revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and market presence.
Cash Flow Management
Effective cash flow management ensures liquidity and financial flexibility, enabling the company to invest in growth opportunities and manage debt efficiently.
Integration Synergies
Successful integration and synergy realization enhance operational efficiency and cost savings, strengthening competitive positioning and profitability.
Negative Factors
Profitability Challenges
Negative profitability impacts financial health and limits reinvestment capacity, posing risks to long-term growth and shareholder returns.
Tariff Costs
Ongoing tariff costs can erode margins and competitiveness, requiring strategic adjustments to mitigate long-term financial impacts.
Impairment Charge
Impairment charges reflect asset valuation issues, potentially impacting financial statements and signaling strategic missteps or market challenges.

JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)

JBT Marel Business Overview & Revenue Model

Company DescriptionJBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyJBT Marel generates revenue through multiple streams, including the sale of processing equipment, systems, and automation solutions to food manufacturers. The company also earns income from service contracts, maintenance, and spare parts, which provide ongoing support to its clients after the initial equipment purchase. Additionally, JBTM forms strategic partnerships with industry leaders and leverages its technological expertise to develop tailored solutions, thereby enhancing its market presence and driving sales. The recurring nature of its service agreements contributes to a stable revenue base, while new product innovations and expansions into emerging markets further bolster its earnings potential.

JBT Marel Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflects a generally positive sentiment with strong revenue performance, improved EBITDA margins, progress in deleveraging, and successful integration synergies. However, challenges remain with tariff costs impacting margins and softness in certain market segments.
Q2-2025 Updates
Positive Updates
Strong Revenue and Order Performance
Total revenue for Q2 2025 was $935 million, exceeding the midpoint of guidance by $35 million. Orders totaled $938 million, with $22 million from favorable FX translation.
Improved EBITDA Margins
Adjusted EBITDA margin was 16.7%, outperforming guidance by 180 basis points, due to favorable revenue mix, productivity improvements, and cost controls.
Progress in Deleveraging
Leverage decreased to below 3.4x from 3.8x in Q1. Bank leverage ratio was 2.8x as of June 30, providing significant liquidity of approximately $1.3 billion.
Integration Synergies Achieved
Year-over-year synergy savings of $5 million in operating expense and $3 million in supply chain, on track for $35-40 million in-year savings, with annualized run rate savings of $80-90 million.
Expanded Portfolio and Cross-Selling Opportunities
Cross-selling and integration of JBT and Marel solutions led to a 15% increase in the pipeline of opportunities in North America. Integrated lines and software provide value to customers.
Negative Updates
Tariff Costs Impacting Margins
Incurred $9 million in gross tariff costs in Q2 2025, with net impact offset by inventory benefits and mitigating actions. Continued tariff challenges expected in the back half of the year.
Soft Performance in Certain Segments
Pharma and pet food demand was softer, while seafood and material handling were neutral. North America was relatively soft, and Asia Pacific remains choppy.
Impairment Charge
An $11 million impairment charge was incurred on a joint venture investment, which was exited as a result of the JBT combination with Marel.
Company Guidance
In the earnings conference call for the second quarter of 2025, JBT Marel provided a comprehensive update on their financial performance and future guidance. The company reported total revenue of $935 million, exceeding expectations by $35 million, with $21 million attributed to favorable foreign exchange impacts. Adjusted EBITDA margins were at 16.7%, outperforming guidance by 180 basis points, driven by a favorable mix of recurring revenue and higher-margin equipment. The company generated strong free cash flow of $88 million in the quarter, contributing to a reduction in leverage to below 3.4x. JBT Marel reestablished full-year guidance, expecting total revenue of $3.7 billion, adjusted EBITDA margins between 15.25% to 16%, and adjusted EPS of $5.45 to $6.15. The integration of JBT and Marel is on track, with synergy savings expected to reach $35 million to $40 million in 2025, with an annualized run rate of $80 million to $90 million by year-end. The backlog stood at $1.4 billion, providing strong support for revenue conversion in the remainder of the year. Despite challenges, such as a $9 million gross tariff cost in Q2, the company is optimistic about continued growth in key markets, notably poultry, and the benefits from its integrated solutions and expanded service network.

JBT Marel Financial Statement Overview

Summary
JBT Marel shows strong revenue growth and effective cash flow management, but faces profitability challenges with a negative net profit margin and return on equity. The balance sheet is stable with moderate leverage.
Income Statement
65
Positive
JBT Marel's income statement shows a strong revenue growth rate of 24.45% in the TTM period, indicating robust top-line expansion. However, the company is facing profitability challenges, as reflected by a negative net profit margin of -5.08% and a declining EBIT margin. The gross profit margin remains stable, but the negative net income suggests operational inefficiencies or high costs impacting the bottom line.
Balance Sheet
70
Positive
The balance sheet of JBT Marel is relatively stable with a moderate debt-to-equity ratio of 0.44 in the TTM period, indicating a balanced approach to leveraging. However, the return on equity has turned negative, reflecting the impact of net losses on shareholder returns. The equity ratio remains healthy, suggesting a solid asset base relative to equity.
Cash Flow
75
Positive
JBT Marel's cash flow statement highlights a strong free cash flow growth of 34.70% in the TTM period, showcasing effective cash generation. The operating cash flow to net income ratio is positive, indicating that the company is generating cash from operations despite net losses. The free cash flow to net income ratio is also strong, suggesting efficient cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.71B1.72B1.66B1.59B1.40B1.73B
Gross Profit969.70M626.50M585.70M529.40M482.10M533.70M
EBITDA187.10M204.20M268.70M212.50M202.80M231.20M
Net Income-137.70M85.40M582.60M137.40M119.10M108.80M
Balance Sheet
Total Assets8.25B3.41B2.71B2.64B2.14B1.81B
Cash, Cash Equivalents and Short-Term Investments111.80M1.23B483.30M71.70M78.80M47.50M
Total Debt1.92B1.25B646.40M977.90M674.40M524.90M
Total Liabilities3.88B1.87B1.22B1.74B1.39B1.17B
Stockholders Equity4.37B1.54B1.49B905.40M750.20M637.10M
Cash Flow
Free Cash Flow281.80M194.70M19.10M50.60M123.20M217.70M
Operating Cash Flow337.20M232.60M74.20M135.20M174.90M252.00M
Investing Cash Flow-1.80B-41.30M729.30M-413.20M-270.50M-37.30M
Financing Cash Flow1.12B561.80M-354.10M270.60M80.80M-207.40M

JBT Marel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price137.35
Price Trends
50DMA
138.45
Negative
100DMA
129.29
Positive
200DMA
124.84
Positive
Market Momentum
MACD
-0.71
Positive
RSI
48.36
Neutral
STOCH
54.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Positive. The current price of 137.35 is below the 20-day moving average (MA) of 138.48, below the 50-day MA of 138.45, and above the 200-day MA of 124.84, indicating a neutral trend. The MACD of -0.71 indicates Positive momentum. The RSI at 48.36 is Neutral, neither overbought nor oversold. The STOCH value of 54.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBTM.

JBT Marel Risk Analysis

JBT Marel disclosed 59 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

JBT Marel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
9.04B40.8913.74%8.90%29.18%
74
Outperform
6.41B32.016.20%-2.67%-17.55%
72
Outperform
7.07B24.3313.12%1.55%3.15%14.18%
71
Outperform
6.74B16.9111.78%-1.70%10.24%
70
Outperform
$7.08B40.40-4.70%0.29%64.69%-112.14%
64
Neutral
5.56B583.780.66%7.88%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JBTM
JBT Marel
137.35
39.84
40.86%
FLS
Flowserve
54.05
3.48
6.88%
SPXC
SPX
182.95
23.91
15.03%
MIDD
The Middleby
133.01
-8.70
-6.14%
GTES
Gates Industrial
24.90
7.06
39.57%
MIR
Mirion Technologies
21.43
10.38
93.94%

JBT Marel Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
JBT Marel Completes $575M Convertible Notes Offering
Positive
Sep 9, 2025

On September 9, 2025, JBT Marel Corporation completed a private offering of $575 million in convertible senior notes due 2030, which includes additional notes acquired by initial purchasers. The company plans to use the net proceeds to repay part of its revolving credit facility and refinance its outstanding convertible senior notes due 2026. This strategic financial move is expected to strengthen JBT Marel’s financial position and support its ongoing operations and growth initiatives in the food and beverage technology sector.

Private Placements and FinancingBusiness Operations and Strategy
JBT Marel Announces Credit Agreement Amendment and Note Offering
Neutral
Sep 3, 2025

On September 3, 2025, JBT Marel Corporation announced a Second Amendment to its Credit Agreement, reducing pricing for its Revolving Credit Facility and allowing issuance of up to $600 million in unsecured convertible notes. Concurrently, the company announced a private offering of $500 million in convertible senior notes due 2030, with an option for an additional $75 million. The proceeds will be used for convertible note hedge transactions and to repay existing debt, potentially impacting the company’s financial strategy and market positioning.

Private Placements and Financing
JBT Marel Amends Credit Agreement to Lower Loan Costs
Positive
Aug 21, 2025

On August 20, 2025, JBT Marel Corporation, a Delaware corporation, executed an amendment to its Second Amended and Restated Credit Agreement to reduce the pricing of its Term B Loans. This amendment removes a ten basis point credit spread adjustment and lowers the applicable margin from SOFR plus 2.00%-2.50% to SOFR plus 1.75%, depending on the company’s Total Net Leverage Ratio. The agreement was executed with various parties including John Bean Technologies Corporation Europe B.V., its subsidiary guarantors, lenders, and Wells Fargo Bank as the administrative agent.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 10, 2025